Send to a Friend Share

deCODE Genetics (DCGN) Receives Market Value Notice from Nasdaq; COO to Resign

December 30, 2009 2:26 PM EST
In a Form 8-K, deCODE Genetics (Nasdaq: DCGN) announced that it received a notice from the Nasdaq stating that for 30 consecutive business days the market value of the publicly held shares of its common stock had been below $15 million, the minimum level required for continued listing on The Nasdaq Global Market. In accordance with Nasdaq Listing Rule 5810(c)(3)(D), deCODE will be provided a period of 90 calendar days in which to regain compliance.

Separately, the company also announced that its COO, Axel Neilsen, will resign from the company, effective January 1, 2010.

You May Also Be Interested In


Related Categories

Corporate News, Management Changes

Add Your Comment





Follow StreetInsider.com On Twitter